POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		1nug PROTEIN-GLUTAMINE
GLUTAMYLTRANSFERASE
E
(Homo
sapiens)		4 / 6LEU A 352
SER A 220
ALA A 221
ARG A 217
None
None
CA  A 703 (-4.5A)
None
1.05A14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		2b25 HYPOTHETICAL PROTEIN
(Homo
sapiens)		4 / 6LEU A 119
SER A 122
ARG A 152
LEU A  73
None
0.91A19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		2mc3 MUS81 ENDONUCLEASE
HOMOLOG (YEAST),
ISOFORM CRA_B
(Homo
sapiens)		4 / 6LEU A  18
TYR A  19
ARG A  39
LEU A  78
None
1.17A25.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		2rgz HEME OXYGENASE 2
(Homo
sapiens)		4 / 6LEU A  74
TYR A  75
ALA A 127
LEU A 109
None
0.80A23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		2xn6 THYROXINE-BINDING
GLOBULIN
(Homo
sapiens)		4 / 6SER A 310
TYR A 309
ALA A 313
LEU A 301
None
1.16A18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		3ibj CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE
(Homo
sapiens)		4 / 6LEU A 671
TYR A 672
ALA A 601
LEU A 677
None
1.11A14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		4bej DYNAMIN 1-LIKE
PROTEIN
(Homo
sapiens)		4 / 6LEU A 624
SER A 627
TYR A 628
ALA A 504
None
0.59A15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		4f52 CULLIN-1
(Homo
sapiens)		4 / 6LEU A 559
SER A 562
TYR A 563
LEU A 555
None
0.91A21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		4ric FANCONI-ASSOCIATED
NUCLEASE 1
(Homo
sapiens)		4 / 6LEU A 417
TYR A 418
ARG A 420
LEU A 450
None
1.07A15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		5dis SNURPORTIN-1
(Homo
sapiens)		4 / 6LEU C 224
SER C 153
ARG C 161
LEU C 155
None
1.09A20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		5fd2 SERINE/THREONINE-PRO
TEIN KINASE B-RAF
(Homo
sapiens)		4 / 6LEU A 654
SER A 657
TYR A 656
LEU A 618
None
0.97A19.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		5lg8 FERRITIN LIGHT CHAIN
(Homo
sapiens)		4 / 6LEU A  28
SER A  31
TYR A  32
ALA A  59
None
0.33A87.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		5y7y ARYL HYDROCARBON
RECEPTOR REPRESSOR
(Homo
sapiens)		4 / 6LEU A  73
SER A  76
TYR A  77
LEU A  55
None
0.75A20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RD0_A_EDPA175_1
(FERRITIN LIGHT CHAIN)		6b5c KATANIN P60
ATPASE-CONTAINING
SUBUNIT A-LIKE 1
(Homo
sapiens)		4 / 6LEU A 380
SER A 416
TYR A 415
ALA A 418
None
1.13A18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		1dql IGM MEZ
IMMUNOGLOBULIN
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
0.99A15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		1ek3 KAPPA-4
IMMUNOGLOBULIN LIGHT
CHAIN VL
(Homo
sapiens)		4 / 8THR A  74
SER A  63
THR A  72
SER A  65
None
0.99A18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		1wtl BENCE-JONES PROTEIN
MCG (LIGHT CHAIN)
(Homo
sapiens)		4 / 8THR A  74
SER A  63
THR A  72
SER A  65
None
0.92A16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		2d7t ANTI
POLYHYDROXYBUTYRATE
ANTIBODY FV, LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
1.01A17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		2f5a PROTEIN (ANTIBODY
2F5 (LIGHT CHAIN))
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
1.03A22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		2kmz TUMOR NECROSIS
FACTOR RECEPTOR
SUPERFAMILY MEMBER
12A
(Homo
sapiens)		4 / 8SER A  16
SER A  34
SER A  27
THR A   6
None
1.03A9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		3auv SC-DSFV DERIVED FROM
THE G6-FAB
(Homo
sapiens)		4 / 8THR A  85
SER A  74
THR A  83
SER A  76
None
1.01A20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		3cdf IMMUNOGLOBULIN LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR A  74
SER A  63
THR A  72
SER A  65
None
0.82A16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		3juy 3B3 SINGLE CHAIN
VARIANT HIV-1
ANTIBODY
(Homo
sapiens)		4 / 8THR B 217
SER B 206
THR B 215
SER B 208
None
0.98A19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		3u6r ANTIBODY 1:7 (LIGHT
CHAIN)
(Homo
sapiens)		4 / 8THR L 222
SER L 211
THR L 220
SER L 213
None
1.01A17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4g6a AP33 LIGHT CHAIN
(Homo
sapiens)		4 / 8THR D  74
SER D  63
THR D  72
SER D  65
None
1.00A20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4hjj ANTI-IL12 ANTI-IL18
DFAB LIGHT CHAIN
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
1.00A21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4iml CROSSED LIGHT CHAIN
(VL-CH1)
(Homo
sapiens)		4 / 8THR L  71
SER L  64
THR L  69
SER L  66
None
0.97A18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4llu LIGHT CHAIN CLAMBDA
(Homo
sapiens)		4 / 8THR B  74
SER B  63
THR B  72
SER B  65
None
1.03A20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4qf1 INFERRED UNMUTATED
ANCESTOR (UA) OF
ANTI-HIV ANTIBODY
CH59
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
1.00A21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4ydv HIV ANTIBODY 7B2
LIGHT CHAIN,IG KAPPA
CHAIN C REGION
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
0.95A21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		4z0x ANTIBODY HC26AM
LIGHT CHAIN VARIABLE
DOMAIN
(Homo
sapiens)		4 / 8THR A  71
SER A  64
THR A  69
SER A  66
None
0.86A15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5b8c PEMBROLIZUMAB LIGHT
CHAIN VARIABLE
REGION (PEMVL)
(Homo
sapiens)		4 / 8THR A  78
SER A  67
THR A  76
SER A  69
None
1.00A18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5esa ANTI-HCV E2
GLYCOPROTEIN FAB
LIGHT CHAIN
(Homo
sapiens)		4 / 8THR B  71
SER B  64
THR B  69
SER B  66
None
0.94A21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5f72 SINGLE CHAIN FV FROM
A FAB
(Homo
sapiens)		4 / 8THR T 215
SER T 204
THR T 213
SER T 206
None
1.01A21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5fv1 VK DOMAIN ANTIBODY
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
0.94A17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5grv HOMO-SPECIFIC
DIABODY LIGHT CHAIN
(Homo
sapiens)		4 / 8THR K 198
SER K 187
THR K 196
SER K 189
None
0.98A18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5gs1 DIABODY
(Homo
sapiens)		4 / 8THR C 198
SER C 187
THR C 196
SER C 189
None
0.99A20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5gs1 LIGHT CHAIN
(Homo
sapiens)		4 / 8THR A  75
SER A  64
THR A  73
SER A  66
None
0.94A17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5gs3 DIABODY PROTEIN
(Homo
sapiens)		4 / 8THR H 198
SER H 187
THR H 196
SER H 189
None
0.96A20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5j13 ANTI-TSLP
FAB-FRAGMENT, LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR B  76
SER B  65
THR B  74
SER B  67
None
1.03A20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5k8d COAGULATION FACTOR
VIII
(Homo
sapiens)		4 / 8THR A  49
SER A 170
SER A 207
SER A 160
None
1.02A18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5ock HUMAN ACPA E4 FAB
FRAGMENT - LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR L  73
SER L  66
THR L  71
SER L  68
None
0.94A13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5ocy ACPA E4 FAB FRAGMENT
- LIGHT CHAIN
(Homo
sapiens)		4 / 8THR L  73
SER L  66
THR L  71
SER L  68
None
1.02A13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5odb D10 FAB FRAGMENT -
LIGHT CHAIN
(Homo
sapiens)		5 / 8THR B  18
SER B  76
SER B  63
THR B  72
SER B  65
None
1.47A14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5u3k DH511.2 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
0.97A20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5u3n DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 8THR L  74
SER L  63
THR L  72
SER L  65
None
1.00A22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		5xj3 IPILIMUMAB-VL
(Homo
sapiens)		4 / 8THR B  75
SER B  64
THR B  73
SER B  66
None
0.96A18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		6ehx SCFV ABVANCE:
INCREASING OUR
KNOWLEDGE OF
ANTIBODY STRUCTURAL
SPACE TO ENABLE
FASTER AND BETTER
DECISION MAKING IN
DRUG DISCOVERY
(Homo
sapiens)		4 / 8THR B 210
SER B 199
THR B 208
SER B 201
None
0.99A18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		6g8r SHORT-CHAIN VARIABLE
FRAGMENT
(Homo
sapiens)		4 / 8THR A 208
SER A 197
THR A 206
SER A 199
None
0.98A16.39